Agile Therapeutics Announces Issuance of Patent for Progestin Patch Designs
June 16, 2016 08:00 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., June 16, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics to Present at the William Blair & Company’s 36th Annual Growth Stock Conference
June 07, 2016 08:00 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., June 07, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics to Present at the Jefferies 2016 Healthcare Conference
June 02, 2016 17:16 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., June 02, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results
March 09, 2016 16:10 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., March 09, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics Appoints Ajit S. Shetty, Ph.D., to Its Board of Directors
February 24, 2016 16:15 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) today announced that Ajit S. Shetty, Ph.D., has been appointed to the Company's Board of Directors,...
Agile Therapeutics, Inc. Announces Full Exercise of Option to Purchase Additional Shares by Underwriters
February 04, 2016 16:10 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s health specialty pharmaceutical company focused on the development and commercialization of...
Agile Therapeutics Receives Approximately $6 Million in Non-Dilutive Funding From New Jersey’s Technology Business Tax Certificate Transfer Program
December 01, 2015 07:45 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Dec. 01, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a specialty pharmaceutical company focused on the development and commercialization of new prescription...
Agile Therapeutics Announces Participation at Upcoming Investor Conferences
November 17, 2015 07:45 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Nov. 17, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Reports Third Quarter Financial Results
November 09, 2015 16:10 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new...
Agile Therapeutics Announces Completion of Patient Enrollment in Twirla(R) Phase 3 SECURE Clinical Trial
October 19, 2015 16:08 ET
|
Agile Therapeutics, Inc.
PRINCETON, N.J., Oct. 19, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women’s health specialty pharmaceutical company focused on the development and commercialization of...